EN
抗体药类似物
Research Grade Caplacizumab
All
TD-HY255016_1.jpg
  • CatalogTD-HY255016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsALX-0081,PMP12A2h1-linkerAAA-PMP12A2h1,caplacizumab-yhdp,CAS:915810-67-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Caplacizumab


Catalog No. TD-HY255016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype VH-VH
Expression system Mammalian Cells
Clonality Monoclonal
Target von Willebrand antigen II, von Willebrand factor, F8VWF, vWF, VWF
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P04275
Form Liquid
Storage buffer 20mM citric acid,6.2% sucrose,0.01% Tween80
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ALX-0081,PMP12A2h1-linkerAAA-PMP12A2h1,caplacizumab-yhdp,CAS:915810-67-2
Background Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY255016_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Caplacizumab.